{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:36:59Z","timestamp":1773952619381,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI23\/000841"],"award-info":[{"award-number":["PI23\/000841"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03617-5","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T09:34:17Z","timestamp":1752917657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meta-analysis identifies the major impact of patient classification on the ACPA association with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)"],"prefix":"10.1186","volume":"27","author":[{"given":"Bartosz","family":"Kaczmarczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Conde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the MARILD network","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"160","key":"3617_CR1","doi-asserted-by":"publisher","first-page":"210011","DOI":"10.1183\/16000617.0011-2021","volume":"30","author":"S Kadura","year":"2021","unstructured":"Kadura S, Raghu G. Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management. Eur Respir Rev. 2021;30(160):210011.","journal-title":"Eur Respir Rev"},{"issue":"12","key":"3617_CR2","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/art.42640","volume":"75","author":"G Koduri","year":"2023","unstructured":"Koduri G, Solomon JJ. Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2023;75(12):2067\u201377","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"3617_CR3","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.42162","volume":"74","author":"PA Juge","year":"2022","unstructured":"Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B, et al. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2022;74(11):1755\u201365.","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"3617_CR4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.reuma.2021.12.006","volume":"19","author":"J Narvaez","year":"2023","unstructured":"Narvaez J, Aburto M, Seoane-Mato D, Bonilla G, Acosta O, Candelas G, Cano-Jimenez E, Castellvi I, Gonzalez-Ruiz JM, Corominas H, et al. Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatol Clin (Engl Ed). 2023;19(2):74\u201381.","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"4","key":"3617_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.reuma.2019.05.007","volume":"17","author":"F Paulin","year":"2021","unstructured":"Paulin F, Doyle TJ, Mercado JF, Fassola L, Fernandez M, Caro F, Alberti ML, Espindola MEC, Buschiazzo E. Development of a risk indicator score for the identification of interstitial lung disease in patients with rheumatoid arthritis. Reumatol Clin (Engl Ed). 2021;17(4):207\u201311.","journal-title":"Reumatol Clin (Engl Ed)"},{"issue":"23","key":"3617_CR6","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","volume":"379","author":"PA Juge","year":"2018","unstructured":"Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, et al. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med. 2018;379(23):2209\u201319.","journal-title":"N Engl J Med"},{"key":"3617_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.823669","volume":"13","author":"J Xue","year":"2022","unstructured":"Xue J, Hu W, Wu S, Wang J, Chi S, Liu X. Development of a Risk Nomogram Model for Identifying Interstitial Lung Disease in Patients With Rheumatoid Arthritis. Front Immunol. 2022;13: 823669.","journal-title":"Front Immunol"},{"issue":"8","key":"3617_CR8","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00296-023-05313-6","volume":"43","author":"GM Koduri","year":"2023","unstructured":"Koduri GM, Podlasek A, Pattapola S, Zhang J, Laila D, Nandagudi A, Dubey S, Kelly C. Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis. Rheumatol Int. 2023;43(8):1515\u201323.","journal-title":"Rheumatol Int"},{"issue":"12","key":"3617_CR9","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1002\/acr.24856","volume":"74","author":"BF Samhouri","year":"2022","unstructured":"Samhouri BF, Vassallo R, Achenbach SJ, Kronzer VL, Davis JM 3rd, Myasoedova E, Crowson CS. Incidence, Risk Factors, and Mortality of Clinical and Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Population-Based Cohort. Arthritis Care Res (Hoboken). 2022;74(12):2042\u20139.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"3617_CR10","doi-asserted-by":"publisher","first-page":"e003059","DOI":"10.1136\/rmdopen-2023-003059","volume":"9","author":"EL Matteson","year":"2023","unstructured":"Matteson EL, Matucci-Cerinic M, Kreuter M, Burmester GR, Dieude P, Emery P, Allanore Y, Pope J, Khanna D. Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review. RMD Open. 2023;9(3):e003059.","journal-title":"RMD Open"},{"issue":"12","key":"3617_CR11","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","volume":"191","author":"TJ Doyle","year":"2015","unstructured":"Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, et al. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med. 2015;191(12):1403\u201312.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3617_CR12","first-page":"10333","volume":"9","author":"W Fan","year":"2016","unstructured":"Fan W, Chen J, Bao C. An updated meta-analysis of association of rheumatoid arthritis related interstitial lung disease with anti-cyclic citrullinated peptide antibody or rheumatoid factor. Int J Clin Exp Med. 2016;9(6):10333\u201343.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"3617_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040465","volume":"11","author":"H Kamiya","year":"2021","unstructured":"Kamiya H, Panlaqui OM. Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody. BMJ Open. 2021;11(3): e040465.","journal-title":"BMJ Open"},{"issue":"11","key":"3617_CR14","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1007\/s10067-021-05808-2","volume":"40","author":"S Xie","year":"2021","unstructured":"Xie S, Li S, Chen B, Zhu Q, Xu L, Li F. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis. Clin Rheumatol. 2021;40(11):4533\u201343.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3617_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286191","volume":"18","author":"M Zhang","year":"2023","unstructured":"Zhang M, Yin J, Zhang X. Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis. PLoS ONE. 2023;18(6): e0286191.","journal-title":"PLoS ONE"},{"issue":"7","key":"3617_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3899\/jrheum.131341","volume":"41","author":"J Zhu","year":"2014","unstructured":"Zhu J, Zhou Y, Chen X, Li J. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol. 2014;41(7):1282\u20139.","journal-title":"J Rheumatol"},{"key":"3617_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M. Introduction to meta-analysis. Chichester, U.K.: John Wiley & Sons; 2009."},{"key":"3617_CR18","unstructured":"Morton SC, Murad MH, O\u2019Connor E, Lee CS, Booth M, Vandermeer BW, Snowden JM, D\u2019Anci KE, Fu R, Gartlehner G, et al. Quantitative Synthesis\u2014An Update. In: Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville (MD), Agency for Healthcare Research and Quality (US). 2008. PMID: 30125065."},{"issue":"4","key":"3617_CR19","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/sim.1040","volume":"21","author":"HC van Houwelingen","year":"2002","unstructured":"van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21(4):589\u2013624.","journal-title":"Stat Med"},{"issue":"3","key":"3617_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1\u201348.","journal-title":"J Stat Softw"},{"key":"3617_CR21","doi-asserted-by":"publisher","unstructured":"Williams DR, Rodriguez JE, B\u00fcrkner P-C. Putting variation into variance: Modeling between-study heterogeneity in Meta-Analysis. PsyArXiv. 2021. https:\/\/doi.org\/10.31234\/osf.io\/9vkqy.","DOI":"10.31234\/osf.io\/9vkqy"},{"key":"3617_CR22","first-page":"372","volume":"29","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA. Brennan SE et al: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;29:372.","journal-title":"Bmj"},{"key":"3617_CR23","doi-asserted-by":"crossref","unstructured":"Alemao E, Doyle T, Sparks J, Rao A, Saini Y, Iannaccone C, Weinblatt ME, Shadick N: Sat0072\u2005Evaluation of Rheumatoid Arthritis Treatments and Joint Outcomes in Rheumatoid Arthritis-Associated Interstitial Lung Disease. In: Saturday, 15 June 2019. 2019: 1099.1092\u20131100.","DOI":"10.1136\/annrheumdis-2019-eular.1766"},{"issue":"9","key":"3617_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","volume":"53","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Saravanan V, Nisar M, Arthanari S, Woodhead FA, Price-Forbes AN, Dawson J, Sathi N, Ahmad Y, Koduri G, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study. Rheumatology (Oxford). 2014;53(9):1676\u201382.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"3617_CR25","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/art.40852","volume":"71","author":"AK Hedstrom","year":"2019","unstructured":"Hedstrom AK, Ronnelid J, Klareskog L, Alfredsson L. Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study. Arthritis Rheumatol. 2019;71(9):1504\u201311.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3617_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13075-019-2079-4","volume":"21","author":"C Regueiro","year":"2019","unstructured":"Regueiro C, Rodriguez-Martinez L, Nuno L, Ortiz AM, Villalba A, Pascual-Salcedo D, Martinez-Feito A, Gonzalez-Alvaro I, Balsa A, Gonzalez A. Improved RA classification among early arthritis patients with the concordant presence of three RA autoantibodies: analysis in two early arthritis clinics. Arthritis Res Ther. 2019;21(1):280.","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"3617_CR27","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/art.40562","volume":"70","author":"MK Verheul","year":"2018","unstructured":"Verheul MK, Bohringer S, van Delft MAM, Jones JD, Rigby WFC, Gan RW, Holers VM, Edison JD, Deane KD, Janssen KMJ, et al. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals. Arthritis Rheumatol. 2018;70(11):1721\u201331.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3617_CR28","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s13075-016-1116-9","volume":"18","author":"S Bugatti","year":"2016","unstructured":"Bugatti S, Bogliolo L, Vitolo B, Manzo A, Montecucco C, Caporali R. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther. 2016;18(1):226.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"3617_CR29","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","volume":"74","author":"C Hecht","year":"2015","unstructured":"Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, Finzel S, Schett G. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis. 2015;74(12):2151\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3617_CR30","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/art.38307","volume":"66","author":"J Sokolove","year":"2014","unstructured":"Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, Michaud K, Sayles H, Reimold AM, Caplan L, et al. Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(4):813\u201321.","journal-title":"Arthritis Rheumatol"},{"key":"3617_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clim.2018.05.004","volume":"195","author":"N Lingampalli","year":"2018","unstructured":"Lingampalli N, Sokolove J, Lahey LJ, Edison JD, Gilliland WR, Holers VM, Deane KD, Robinson WH. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis. Clin Immunol. 2018;195:119\u201326.","journal-title":"Clin Immunol"},{"issue":"1","key":"3617_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41927-024-00389-4","volume":"8","author":"JA Sparks","year":"2024","unstructured":"Sparks JA, Dieude P, Hoffmann-Vold AM, Burmester GR, Walsh SL, Kreuter M, Stock C, Sambevski S, Alves M, Emery P. Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis. BMC Rheumatol. 2024;8(1):19.","journal-title":"BMC Rheumatol"},{"issue":"10","key":"3617_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","volume":"15","author":"D Wang","year":"2019","unstructured":"Wang D, Zhang J, Lau J, Wang S, Taneja V, Matteson EL, Vassallo R. Mechanisms of lung disease development in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(10):581\u201396.","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"3617_CR34","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1172\/JCI28756","volume":"116","author":"J Rangel-Moreno","year":"2006","unstructured":"Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, Randall TD. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest. 2006;116(12):3183\u201394.","journal-title":"J Clin Invest"},{"issue":"9","key":"3617_CR35","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1136\/annrheumdis-2015-208216","volume":"75","author":"G Reynisdottir","year":"2016","unstructured":"Reynisdottir G, Olsen H, Joshua V, Engstrom M, Forsslund H, Karimi R, Skold CM, Nyren S, Eklund A, Grunewald J, et al. Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis. Ann Rheum Dis. 2016;75(9):1722\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3617_CR36","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/art.40401","volume":"70","author":"MK Demoruelle","year":"2018","unstructured":"Demoruelle MK, Bowers E, Lahey LJ, Sokolove J, Purmalek M, Seto NL, Weisman MH, Norris JM, Kaplan MJ, Holers VM, et al. Antibody Responses to Citrullinated and Noncitrullinated Antigens in the Sputum of Subjects With Rheumatoid Arthritis and Subjects at Risk for Development of Rheumatoid Arthritis. Arthritis Rheumatol. 2018;70(4):516\u201327.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"3617_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/art.38201","volume":"66","author":"G Reynisdottir","year":"2014","unstructured":"Reynisdottir G, Karimi R, Joshua V, Olsen H, Hensvold AH, Harju A, Engstrom M, Grunewald J, Nyren S, Eklund A, et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 2014;66(1):31\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"3617_CR38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/art.40900","volume":"71","author":"BR England","year":"2019","unstructured":"England BR, Duryee MJ, Roul P, Mahajan TD, Singh N, Poole JA, Ascherman DP, Caplan L, Demoruelle MK, Deane KD, et al. Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2019;71(9):1483\u201393.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"3617_CR39","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/art.37881","volume":"65","author":"L Harlow","year":"2013","unstructured":"Harlow L, Rosas IO, Gochuico BR, Mikuls TR, Dellaripa PF, Oddis CV, Ascherman DP. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum. 2013;65(4):869\u201379.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3617_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","volume":"79","author":"R Castellanos-Moreira","year":"2020","unstructured":"Castellanos-Moreira R, Rodriguez-Garcia SC, Gomara MJ, Ruiz-Esquide V, Cuervo A, Casafont-Sole I, Ramirez J, Holgado S, Gomez-Puerta JA, Canete JD, et al. Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Ann Rheum Dis. 2020;79(5):587\u201394.","journal-title":"Ann Rheum Dis"},{"key":"3617_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.627986","volume":"12","author":"C Gronwall","year":"2021","unstructured":"Gronwall C, Liljefors L, Bang H, Hensvold AH, Hansson M, Mathsson-Alm L, Israelsson L, Joshua V, Svard A, Stalesen R, et al. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis. Front Immunol. 2021;12: 627986.","journal-title":"Front Immunol"},{"issue":"7","key":"3617_CR42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/annrheumdis-2018-214950","volume":"78","author":"ASB Kampstra","year":"2019","unstructured":"Kampstra ASB, Dekkers JS, Volkov M, Dorjee AL, Hafkenscheid L, Kempers AC, van Delft M, Kissel T, Reijm S, Janssen GMC, et al. Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification. Ann Rheum Dis. 2019;78(7):908\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3617_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","volume":"13","author":"J Shi","year":"2014","unstructured":"Shi J, van Veelen PA, Mahler M, Janssen GM, Drijfhout JW, Huizinga TW, Toes RE, Trouw LA. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev. 2014;13(3):225\u201330.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3617_CR44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","volume":"13","author":"LA Trouw","year":"2017","unstructured":"Trouw LA, Rispens T, Toes REM. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(6):331\u20139.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"3617_CR45","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/art.40738","volume":"71","author":"C Regueiro","year":"2019","unstructured":"Regueiro C, Rodriguez-Rodriguez L, Triguero-Martinez A, Nuno L, Castano-Nunez AL, Villalva A, Perez-Pampin E, Lopez-Golan Y, Abasolo L, Ortiz AM, et al. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis. Arthritis Rheumatol. 2019;71(3):331\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"3617_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180144","volume":"12","author":"L Vidal-Bralo","year":"2017","unstructured":"Vidal-Bralo L, Perez-Pampin E, Regueiro C, Montes A, Varela R, Boveda MD, Gomez-Reino JJ, Gonzalez A. Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients. PLoS ONE. 2017;12(7): e0180144.","journal-title":"PLoS ONE"},{"issue":"1","key":"3617_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12891-021-04985-0","volume":"23","author":"S Oka","year":"2022","unstructured":"Oka S, Higuchi T, Furukawa H, Shimada K, Okamoto A, Hashimoto A, Komiya A, Saisho K, Yoshikawa N, Katayama M, et al. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. BMC Musculoskelet Disord. 2022;23(1):46.","journal-title":"BMC Musculoskelet Disord"},{"issue":"4","key":"3617_CR48","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10654-018-0360-5","volume":"33","author":"AK Hedstrom","year":"2018","unstructured":"Hedstrom AK, Stawiarz L, Klareskog L, Alfredsson L. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study. Eur J Epidemiol. 2018;33(4):415\u201323.","journal-title":"Eur J Epidemiol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03617-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:42:59Z","timestamp":1757259779000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03617-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3617"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03617-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.24.25322770","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"23 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}